New Delhi: The Drugs Controller General of India (DCGI) has directed all pharmaceutical manufacturers and importers to immediately stop surrogate, or indirect, promotion of...
Abbott India Ltd has partnered with Novo Nordisk to market a new brand of semaglutide in India, the diabetes drug behind blockbuster weight-loss therapy...
Novo Nordisk shares tumbled in pre-market trading on Monday after its experimental obesity drug CagriSema failed to match the weight-loss efficacy of Eli Lilly’s...
United States pharmaceuticals company Hims & Hers Health Inc. has announced that it will stop selling a copycat version of Novo Nordisk's Wegovy weight-loss...